Search

everythinglearnresearchcommunity

for

Search:↓

The nutritional supplement Pilopeptan® WOMAN improved hair growth and thickness in women with hair loss.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

New hair loss treatments could be improved by using combined biological markers.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Men with baldness, ear creases, and hairy ears have a higher risk of heart disease.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

The document concludes that personalized treatment plans for hair loss in Asian men are necessary and more research is needed to develop effective guidelines.

Inflammation linked to the immune response may play a role in causing various types of hair loss.

Protein profiling of forehead skin can help distinguish between frontal fibrosing alopecia and androgenetic alopecia.

The hemp extract significantly increased hair regrowth in both men and women without any side effects.

Severe hair loss in Chinese men is linked to high blood pressure, while in women, it's linked to larger waist size and cholesterol issues.

Combining micro-needling, LED therapy, and growth factors with Finasteride® significantly improves hair growth.

Combining laser therapy with platelet-rich plasma improves hair growth in people with hair loss.

Using both platelet-rich plasma and minoxidil together gives the best results for hair growth in male rats with hair loss.

The FAW-FS algorithm improves depression recognition, and psychological interventions help AGA patients' mental health.

Androgenetic alopecia is linked to a higher risk of coronary heart disease due to certain genetic factors and high homocysteine levels.

A new method using fat tissue cells may help treat hair loss.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

Alopecia patients have more mast cells in their scalps, especially in severe cases and older age, with alopecia areata showing the highest increase.

Mutations in the AR gene cause hair thinning and loss.

People with androgenetic alopecia have a higher risk of heart disease.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Dutasteride injections can help hair growth in androgenic alopecia but need more research for long-term use.

Androgenetic alopecia in teens is linked to obesity and other metabolic risks, needing early diagnosis and management.

Autologous cellular micrografts improve hair density and thickness in the short term for androgenetic alopecia.

Combining botulinum toxin type A with Minoxidil significantly improves hair growth and patient satisfaction in male hair loss.

Plum-blossom needle therapy shows promise for treating hair loss but needs more research.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

PRP therapy helps improve hair growth and is safe for treating hair loss.

Alternative treatments show promise for hair growth beyond traditional methods.